Publications by authors named "Sandra Collette"

Claim this Profile
R
Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysis.
Najlaa Alyamani, André Abrunhosa-Branquinho, Coreen Corning, Marjan Sharabiani, Pierre Castadot, Sandra Collette

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score" [Eur. Urol. 83(5) (2024) 432-440].
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, Jürgen E Gschwend, Yoshihiko Tomita, Sandra Collette

Eur Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-free Survival Analysis for Patients with High-risk Muscle-invasive Urothelial Carcinoma from the Randomized CheckMate 274 Trial by PD-L1 Combined Positive Score and Tumor Cell Score.
Matthew D Galsky, Dean F Bajorin, Johannes Alfred Witjes, Jürgen E Gschwend, Yoshihiko Tomita, Sandra Collette

Eur Urol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Dean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, Michael Schenker, Begoña P Valderrama, Sandra Collette

Future Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Yoshihiko Tomita, Ko Kobayashi, Go Kimura, Mototsugu Oya, Hirotsugu Uemura, Sandra Collette

Jpn J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response.
Lalitha K Shankar, Erich Huang, Saskia Litiere, Otto S Hoekstra, Larry Schwartz, Sandra Collette

Clin Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply.
Dean F Bajorin, Sandra Collette, Matthew D Galsky

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
Dean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, Michael Schenker, Begoña P Valderrama, Sandra Collette

N Engl J Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275.
Matthew D Galsky, Abdel Saci, Peter M Szabo, G Celine Han, Gary Grossfeld, Sandra Collette

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME).
Roderick Emile De Bruijn, Peter Mulders, Michael A Jewett, John Wagstaff, Johan V Van Thienen, Sandra Collette, Laurence Collette

Eur Urol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.
Chikara Ohyama, Takahiro Kojima, Tsunenori Kondo, Yoshio Naya, Takamitsu Inoue, Sandra Collette

Int J Clin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability and reproducibility of relative cerebral blood volume measurement of recurrent glioma in a multicentre trial setting.
Marion Smits, Martin Bendszus, Sandra Collette, Linda A Postma, Frederic Dhermain

Eur J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Thomas M Churilla, Imran H Chowdhury, Elizabeth Handorf, Laurence Collette, Sandra Collette

JAMA Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.
Axel Bex, Peter Mulders, Michael Jewett, John Wagstaff, Johannes V van Thienen, Sandra Collette, Laurence Collette

JAMA Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
Damien C Weber, Carmen Ares, Salvador Villa, Saskia M Peerdeman, Laurette Renard, Laurence Collette, Sandra Collette

Radiother Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial.
Patrick Schöffski, Jozef Sufliarsky, Hans Gelderblom, Jean-Yves Blay, Sandra J Strauss, Sandra Collette

Lancet Respir Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE'.
Patrick Schöffski, Agnieszka Wozniak, Michael G Leahy, Steinar Aamdal, Piotr Rutkowski, Sandra Collette

Eur J Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.
André N Abrunhosa-Branquinho, Raquel Bar-Deroma, Sandra Collette, Enrico Clementel, Yan Liu

Radiother Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Patrick Schöffski, Agnieszka Wozniak, Bernard Escudier, Piotr Rutkowski, Alan Anthoney, Sandra Collette

Eur J Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
Melissa Christiaens, Sandra Collette, Jens Overgaard, Vincent Gregoire, Joanna Kazmierska

Radiother Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging biomarker roadmap for cancer studies.
James P B O'Connor, Eric O Aboagye, Judith E Adams, Hugo J W L Aerts, Sally F Barrington, Sandra Collette

Nat Rev Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RECIST - learning from the past to build the future.
Saskia Litière, Sandra Collette, Elisabeth G E de Vries, Lesley Seymour, Jan Bogaerts

Nat Rev Clin Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Conny Vrieling, Erik van Werkhoven, Philippe Maingon, Philip Poortmans, Caroline Weltens, Sandra Collette, Laurence Collette

JAMA Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beam Output Audit results within the EORTC Radiation Oncology Group network.
Coen W Hurkmans, Melissa Christiaens, Sandra Collette, Damien Charles Weber

Radiat Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A risk management approach for imaging biomarker-driven clinical trials in oncology.
Yan Liu, Nandita M deSouza, Lalitha K Shankar, Hans-Ulrich Kauczor, Siegfried Trattnig, Sandra Collette

Lancet Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis